For the year ending 2025-12-31, INDV has $1,201M in assets. $1,300M in debts. $195M in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 195 | 319 | ||
| Short-term investments | 0 | 1 | ||
| Accounts receivable, net of allowances of 4 (2025) and 3 (2024) | 253 | 254 | ||
| Inventories | 153 | 178 | ||
| Prepaid expenses and other current assets | - | 53 | ||
| Escrow settlement asset | - | 0 | ||
| Prepaid expenses | 34 | - | ||
| Current tax receivable | 2 | 34 | ||
| Other current assets | 16 | - | ||
| Total current assets | 652 | 839 | ||
| Long-term investments | 28 | 27 | ||
| Property, plant and equipment, net | 144 | 100 | ||
| Operating lease right of use assets, net | 26 | 39 | ||
| Goodwill and other intangible assets, net | 2 | 6 | ||
| Deferred tax assets | 323 | 280 | ||
| Other noncurrent assets | 27 | 29 | ||
| Total assets | 1,201 | 1,319 | ||
| Accrued rebates and product returns | 582 | 562 | ||
| Accounts payable and accrued expenses | 250 | 232 | ||
| Accrued litigation settlement expenses, current | 42 | 99 | ||
| Current portion of long-term debt | 29 | 18 | ||
| Operating lease liabilities, current | 10 | 10 | ||
| Income taxes payable | 2 | 7 | ||
| Other current liabilities | 0 | 11 | ||
| Total current liabilities | 914 | 939 | ||
| Long-term debt, less current portion | 290 | 315 | ||
| Accrued litigation settlement expenses, noncurrent | 52 | 365 | ||
| Operating lease liabilities, noncurrent | 22 | 32 | ||
| Other noncurrent liabilities | 21 | 18 | ||
| Total liabilities | 1,300 | 1,668 | ||
| Common stock, par value 0.50 per share issued shares 125 (2025) and 125 (2024) | 62 | 62 | ||
| Additional paid-in capital | 112 | 90 | ||
| Share repurchase commitment | 0 | 10 | ||
| Accumulated other comprehensive loss | -30 | -36 | ||
| Accumulated deficit | -243 | -454 | ||
| Total stockholders' deficit | -98 | -348 | ||
| Total liabilities and stockholders' deficit | 1,201 | 1,319 | ||
Indivior Pharmaceuticals, Inc. (INDV)
Indivior Pharmaceuticals, Inc. (INDV)